Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.53), $0.04 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reddit to join S&P 500 index on Aug. 18, shares leap
• Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses